Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ana R Pinto, Jani Silva, Ricardo Pinto & Rui Medeiros. (2020) Aggressive Prostate Cancer Phenotype and Genome-Wide Association Studies: Where are we Now?. Pharmacogenomics 21:7, pages 487-503.
Read now
Read now
Articles from other publishers (12)
Min Ma, Yazhi Zhu, Changkai Xiao, Ruidong Li, Xingyu Cao, Ran Kang, Xiaolan Wang & Ermao Li. (2024) Novel insights into RB1 in prostate cancer lineage plasticity and drug resistance. Tumori Journal.
Crossref
Crossref
Munir Al-Ghazawi, Hamza Salameh, Samuel Amo-Afful, Seren Khasawneh & Rami Ghanem. (2023) An In-Depth Look Into the Epidemiological and Etiological Aspects of Prostate Cancer: A Literature Review. Cureus.
Crossref
Crossref
Yuling Zhao, Xiaochun Tang, Yifan Zhao, Yan Yu & Shuzhen Liu. (2021) Diagnostic significance of microRNA-1255b-5p in prostate cancer patients and its effect on cancer cell function. Bioengineered 12:2, pages 11451-11460.
Crossref
Crossref
Richard J. Rebello, Christoph Oing, Karen E. Knudsen, Stacy Loeb, David C. Johnson, Robert E. Reiter, Silke Gillessen, Theodorus Van der Kwast & Robert G. Bristow. (2021) Prostate cancer. Nature Reviews Disease Primers 7:1.
Crossref
Crossref
Mahbubl Ahmed, Chee Goh, Edward Saunders, Clara Cieza-Borrella, Zsofia Kote-Jarai, Fredrick R. Schumacher & Ros Eeles. (2019) Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT. Prostate Cancer and Prostatic Diseases 23:2, pages 333-342.
Crossref
Crossref
Indu Kohaar, Qiyuan Li, Yongmei Chen, Lakshmi Ravindranath, Denise Young, Amina Ali, Isabell A. Sesterhenn, Inger L. Rosner, Jennifer Cullen, Shiv Srivastava, Matthew Freedman & Gyorgy Petrovics. (2020)
Association of germline genetic variants with
TMPRSS2-ERG
fusion status in prostate cancer
. Oncotarget 11:15, pages 1321-1333.
Crossref
Crossref
Elizabeth K. Bancroft, Kelly Kohut & Rosalind A. Eeles. (2020) The New Genomics Era: Integration of genomics into mainstream oncology and implications for psycho‐oncological care. Psycho-Oncology 29:3, pages 453-460.
Crossref
Crossref
Prakash Chand Sharma & Kalyani Verma. 2020. Precision Medicine for Investigators, Practitioners and Providers. Precision Medicine for Investigators, Practitioners and Providers
167
178
.
Takahiro Kimura & Shin Egawa. (2018) Epidemiology of prostate cancer in Asian countries. International Journal of Urology 25:6, pages 524-531.
Crossref
Crossref
Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Alberto Bossi, Rob Bristow, Brett Carver, Daniel Castellano, Byung Ha Chung, Noel Clarke, Gedske Daugaard, Ian D. Davis, Johann de Bono, Rodolfo Borges dos Reis, Charles G. Drake, Ros Eeles, Eleni Efstathiou, Christopher P. Evans, Stefano Fanti, Felix Feng, Karim Fizazi, Mark Frydenberg, Martin Gleave, Susan Halabi, Axel Heidenreich, Celestia S. Higano, Nicolas James, Philip Kantoff, Pirkko-Liisa Kellokumpu-Lehtinen, Raja B. Khauli, Gero Kramer, Chris Logothetis, Fernando Maluf, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Vedang Murthy, William Oh, Piet Ost, Anwar R. Padhani, Chris Parker, Colin C. Pritchard, Mack Roach, Mark A. Rubin, Charles Ryan, Fred Saad, Oliver Sartor, Howard Scher, Avishay Sella, Neal Shore, Matthew Smith, Howard Soule, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher Sweeney, Matthew R. Sydes, Ian Tannock, Bertrand Tombal, Riccardo Valdagni, Thomas Wiegel & Aurelius Omlin. (2018) Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. European Urology 73:2, pages 178-211.
Crossref
Crossref
J.M. Cozar, I. Robles-Fernandez, L.J. Martinez-Gonzalez, M. Pascual-Geler, Alba Rodriguez-Martinez, M.J. Serrano, J.A. Lorente & M.J. Alvarez-Cubero. (2018) Genetic markers a landscape in prostate cancer. Mutation Research/Reviews in Mutation Research 775, pages 1-10.
Crossref
Crossref
William B. Coleman. 2018. Molecular Pathology. Molecular Pathology
555
568
.